CYTK Trading Analysis - 09/15/2026 04:06 PM โ€” TRU-SENTIMENT

CYTK (Cytokinetics Inc.) at $69.33. True Sentiment Bullish, delta 40-60 call 97% / put 3%, call $1,736,890 vs put $59,860. RSI 32.5.

TRU-SENTIMENT ยท DeltaNeutral

CYTK Trading Analysis - 09/15/2026 04:06 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

CYTK (Cytokinetics Inc.) at $69.33. True Sentiment Bullish, delta 40-60 call 97% / put 3%, call $1,736,890 vs put $59,860. RSI 32.5.

Symbol
CYTK
Price
$69.33
Article bias (separate from True Sentiment)
bearish
Conviction
medium
Published
2026-09-15 16:06:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume: Calls account for 96.7% of the total dollar volume, indicating strong bullish conviction.

Key Statistics: CYTK

$72.45 +0.00%
52-Week Range
$47.22 - $88.31
Market Cap
$18.00M
P/E (TTM)
-10.03
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$2.10M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)-10.03
P/E (Forward)N/A
PEG RatioN/A
Price/Book-0.10

Profitability

EPS (Trailing)$-7.22
EPS (Forward)N/A
ROE515.31%
Net Margin-1,321.12%

Financial Health

Revenue (TTM)$67.67M
Debt/Equity-12.09
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for CYTK include:

  • Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
  • Cytokinetics Reports Financial Results for the Second Quarter of 2026 and Provides Business Update
  • Cytokinetics to Participate in the 2026 Healthcare Conference

These headlines suggest that CYTK has been making progress with its drug applications and reporting financial results, which could be impacting the stock's performance.

Fundamental Analysis:

Based on the provided fundamentals data:

  • Total Revenue: $67,670,000
  • Trailing EPS: -$7.22
  • Trailing P/E: -10.03
  • Price to Book: -0.10
  • Debt to Equity: -12.09
  • Return on Equity: 5.15%
  • Operating Margins: -10.46%
  • Profit Margins: -13.21%

The negative EPS and profit margins indicate that the company is currently not profitable. The high debt to equity ratio and negative price to book value also raise concerns. However, the return on equity is positive, suggesting some level of efficiency in generating profits.

Current Market Position:

Current price: $69.35

Recent price action: The stock has been trending downward, with a significant drop in the past few days.

Key support and resistance levels:

Level Price
Support $68.55
Resistance $74.65

Technical Analysis:

Technical Indicators

RSI (14)
32.54
MACD
-1.61
50-day SMA
$77.72
20-day SMA
$74.56
5-day SMA
$72.66

The RSI is in the oversold territory, which could indicate a potential reversal. The MACD is bearish, and the stock is trading below its 50-day and 20-day SMAs, indicating a downtrend.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume: Calls account for 96.7% of the total dollar volume, indicating strong bullish conviction.

Key Price Levels:

Support
$68.55
Resistance
$74.65

The stock is currently trading near its support level of $68.55.

25-Day Price Forecast:

CYTK is projected for $65.00 to $70.00

Based on the current technical trends, momentum, and indicators, the stock price is expected to trade within this range in the next 25 days. The projection considers the 50-day SMA, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three recommended defined risk strategies:

  • Bull Call Spread: Buy CYTK 2026-10-16 65.0 C @ $5.4 and Sell CYTK 2026-10-16 70.0 C @ $3.1. Net Debit: $2.3. Risk/Reward: 1:2.17
  • Bear Put Spread: Buy CYTK 2026-10-16 65.0 P @ $1.35 and Sell CYTK 2026-10-16 60.0 P @ $0.0. Net Debit: $1.35. Risk/Reward: 1:1.52
  • Iron Condor: Buy CYTK 2026-10-16 60.0 P @ $0.0 and Sell CYTK 2026-10-16 65.0 P @ $1.35. Buy CYTK 2026-10-16 70.0 C @ $3.1 and Sell CYTK 2026-10-16 75.0 C @ $1.25. Net Debit: $4.4. Risk/Reward: 1:1.25

Risk Factors:

  • Technical warning signs: The stock is trading below its 50-day and 20-day SMAs.
  • Sentiment divergences: The technical indicators are bearish, while the options sentiment is bullish.
  • Volatility and ATR considerations: The ATR is $2.92, indicating moderate volatility.

Summary & Conviction Level:

Overall bias: Bearish

Conviction level: Medium

One-line trade idea: CYTK may experience a short-term bounce due to bullish options sentiment, but the overall trend remains bearish.


View CYTK Options Chain

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.